Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Автори: | Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR |
---|---|
Формат: | Conference item |
Мова: | English |
Опубліковано: |
Springer Nature
2019
|
Схожі ресурси
Схожі ресурси
-
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
за авторством: Xu, S, та інші
Опубліковано: (2021) -
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
за авторством: Wamil, M, та інші
Опубліковано: (2020) -
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
за авторством: Leal, J, та інші
Опубліковано: (2022) -
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
за авторством: Holman, R, та інші
Опубліковано: (2017) -
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
за авторством: Currie, G, та інші
Опубліковано: (2017)